Javier T Gonzalez1, Emma J Stevenson. 1. Brain, Performance and Nutrition Research Centre, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, NE1 8ST, UK, javier.gonzalez@northumbria.ac.uk.
Abstract
PURPOSE: This study determined whether calcium co-ingestion potentiates postprandial GIP(1-42) and GLP-1 concentrations in humans and the concomitant impact on insulin, appetite sensations and substrate metabolism. METHODS:Ten healthy males consumed twoenergy- and macronutrient-matched meals in a double-blind, randomized, crossover design. The calcium content of the control meal was 3 mg/kg body mass, which was increased to 15 mg/kg body mass with calcium co-ingestion. Circulating concentrations of GIP(1-42), GLP-1 and insulin were determined over a 180-min postprandial period, followed by 60 min of exercise. Visual analogue scales were used to determine subjective appetite sensations. Rates of energy expenditure and substrate (lipid and carbohydrate) oxidation were estimated using indirect calorimetry. RESULTS:Calcium co-ingestion resulted in a 47% increase in GIP(1-42), a 22% increase in GLP-1 and a 19% increase in insulin areas under the curve for the 120 min following consumption (all P < 0.05). Furthermore, appetite sensations were suppressed by calcium co-ingestion by 12% (P = 0.034). No differences, however, were observed in substrate metabolism (P > 0.05). CONCLUSION: Ingestion of a high-calcium meal potentiates postprandial GIP(1-42), GLP-1 and insulin concentrations in humans. Subjective appetite is also temporarily suppressed, although substrate metabolism is unaffected.
RCT Entities:
PURPOSE: This study determined whether calcium co-ingestion potentiates postprandial GIP(1-42) and GLP-1 concentrations in humans and the concomitant impact on insulin, appetite sensations and substrate metabolism. METHODS: Ten healthy males consumed two energy- and macronutrient-matched meals in a double-blind, randomized, crossover design. The calcium content of the control meal was 3 mg/kg body mass, which was increased to 15 mg/kg body mass with calcium co-ingestion. Circulating concentrations of GIP(1-42), GLP-1 and insulin were determined over a 180-min postprandial period, followed by 60 min of exercise. Visual analogue scales were used to determine subjective appetite sensations. Rates of energy expenditure and substrate (lipid and carbohydrate) oxidation were estimated using indirect calorimetry. RESULTS:Calcium co-ingestion resulted in a 47% increase in GIP(1-42), a 22% increase in GLP-1 and a 19% increase in insulin areas under the curve for the 120 min following consumption (all P < 0.05). Furthermore, appetite sensations were suppressed by calcium co-ingestion by 12% (P = 0.034). No differences, however, were observed in substrate metabolism (P > 0.05). CONCLUSION: Ingestion of a high-calcium meal potentiates postprandial GIP(1-42), GLP-1 and insulin concentrations in humans. Subjective appetite is also temporarily suppressed, although substrate metabolism is unaffected.
Authors: Robert B Wallace; Jean Wactawski-Wende; Mary Jo O'Sullivan; Joseph C Larson; Barbara Cochrane; Margery Gass; Kamal Masaki Journal: Am J Clin Nutr Date: 2011-04-27 Impact factor: 7.045
Authors: E O Billington; S M Bristow; G D Gamble; J A de Kwant; A Stewart; B V Mihov; A M Horne; I R Reid Journal: Osteoporos Int Date: 2016-08-20 Impact factor: 4.507
Authors: Dean M Allerton; Matthew D Campbell; Javier T Gonzalez; Penny L S Rumbold; Daniel J West; Emma J Stevenson Journal: Nutrients Date: 2016-02-25 Impact factor: 5.717
Authors: Yung-Chih Chen; Harry A Smith; Aaron Hengist; Oliver J Chrzanowski-Smith; Ulla Ramer Mikkelsen; Harriet A Carroll; James A Betts; Dylan Thompson; John Saunders; Javier T Gonzalez Journal: Eur J Nutr Date: 2019-09-17 Impact factor: 5.614
Authors: Javier T Gonzalez; Marlou L Dirks; Andrew M Holwerda; Imre W K Kouw; Luc J C van Loon Journal: Eur J Appl Physiol Date: 2020-07-10 Impact factor: 3.078
Authors: Kieran Smith; Guy S Taylor; Dean M Allerton; Lise Hoej Brunsgaard; Kelly A Bowden Davies; Emma J Stevenson; Daniel J West Journal: Front Endocrinol (Lausanne) Date: 2021-06-18 Impact factor: 5.555